Robert J Van Gulick (Robert Van Gulick)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Richard P Tobin, Dasha T Cogswell, Victoria M Cates, Dana M Davis, Jessica S W Borgers, Robert J Van Gulick, Elizabeth Katsnelson, Kasey L Couts, Kimberley R Jordan, Dexiang Gao, Eduardo Davila, Theresa M Medina, Karl D Lewis, Rene Gonzalez, Ross W McFarland, William A Robinson, Martin D McCarter
Targeting MDSC differentiation using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Chiara R Dart, Nabanita Mukherjee, Carol M Amato, Anabel Goulding, Morgan MacBeth, Robert J Van Gulick, Kasey L Couts, James R Lambert, David A Norris, William A Robinson, Yiqun G Shellman
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)